<![CDATA[19 Targeted Axillary Dissection—Does the Biopsy-Proven Node Need to Be Localized? A Retrospective Review of Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy]]>
Read the full article2d agoen
You might also wanna read
Robotic-Assisted Versus Endoscopic-Assisted Axillary Lymph Node Dissection in Breast Cancer
Conditions : Breast Neoplasms Sponsors : Guangzhou Women and Children's Medical Center Active, not recruiting
clinicaltrials.gov·2d ago
Performance of Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early Triple-Negative Breast Cancer
Conditions : Breast Cancer (Triple Negative Breast Cancer (TNBC)) Interventions : Other: Non interventional study Sponsors : Assistance Publ
clinicaltrials.gov·4d ago
Augmented-Reality ICG Fluorescence Second-Look for Residual Nodal Disease After Axillary Dissection in Breast Cancer
Conditions : Breast Cancer; Breast Neoplasms; Sentinel Lymph Node; Lymphatic Metastasis Interventions : Device: Augmented-reality ICG fluore
clinicaltrials.gov·1d ago
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy
Methylation-based ctDNA monitoring in 57 patients closely reflects outcomes in ER+, HER2- metastatic breast cancer during CDK4/6 inhibitor t
doi.org·3d ago
Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer
Conditions : Breast Cancer Interventions : Other: Breast-conserving surgery, postoperative radiotherapy and individualized adjuvant systemic
clinicaltrials.gov·10d ago
<![CDATA[Rationale and Timing: The Evolving Role of BCMA-Targeted Therapies in Relapsed/Refractory Multiple Myeloma ]]>
Pharmacy Times·1d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.